newsfilter
← Latest News
Business Wire·

TherapeuticsMD Announces First Quarter 2022 Financial Results

- Quarterly total net product revenue of $19.3 million -- ANNOVERA® TRx of 8,014, an increase of 27% over Q1 2021 -- Announced and completed vitaCare divestiture in five weeks -- Conference call scheduled for 4:30 p.m. ET today - TherapeuticsMD,